155 related articles for article (PubMed ID: 31280076)
1. Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.
Dreimüller N; Lieb K; Tadić A; Engelmann J; Wollschläger D; Wagner S
J Affect Disord; 2019 Sep; 256():524-531. PubMed ID: 31280076
[TBL] [Abstract][Full Text] [Related]
2. Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication.
Toups MS; Myers AK; Wisniewski SR; Kurian B; Morris DW; Rush AJ; Fava M; Trivedi MH
Psychosom Med; 2013; 75(9):863-72. PubMed ID: 24163386
[TBL] [Abstract][Full Text] [Related]
3. The association of body mass index (BMI) with treatment outcomes in patients with major depressive disorder.
Xiao L; Zhou J; Galling B; Chen RS; Wang G
J Affect Disord; 2021 Feb; 281():799-804. PubMed ID: 33243554
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database.
Kraus C; Kautzky A; Watzal V; Gramser A; Kadriu B; Deng ZD; Bartova L; Zarate CA; Lanzenberger R; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fanelli G; Serretti A; Kasper S
J Affect Disord; 2023 Aug; 335():349-357. PubMed ID: 37196934
[TBL] [Abstract][Full Text] [Related]
5. Overweight and obesity affect treatment response in major depression.
Kloiber S; Ising M; Reppermund S; Horstmann S; Dose T; Majer M; Zihl J; Pfister H; Unschuld PG; Holsboer F; Lucae S
Biol Psychiatry; 2007 Aug; 62(4):321-6. PubMed ID: 17241618
[TBL] [Abstract][Full Text] [Related]
6. Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.
Lin CH; Chen CC; Wong J; McIntyre RS
J Affect Disord; 2014 Jun; 161():123-6. PubMed ID: 24751319
[TBL] [Abstract][Full Text] [Related]
7. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
[TBL] [Abstract][Full Text] [Related]
9. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
10. Weight gain in relation to major depression and antidepressant medication use.
Patten SB; Williams JV; Lavorato DH; Khaled S; Bulloch AG
J Affect Disord; 2011 Nov; 134(1-3):288-93. PubMed ID: 21774992
[TBL] [Abstract][Full Text] [Related]
11. Excess body weight and specific types of depressive symptoms: Is there a mediating role of systemic low-grade inflammation?
Chu K; Cadar D; Iob E; Frank P
Brain Behav Immun; 2023 Feb; 108():233-244. PubMed ID: 36462595
[TBL] [Abstract][Full Text] [Related]
12. Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years.
Wagner S; Wollschläger D; Dreimüller N; Engelmann J; Herzog DP; Roll SC; Tadić A; Lieb K
Compr Psychiatry; 2020 May; 99():152170. PubMed ID: 32146314
[TBL] [Abstract][Full Text] [Related]
13. Surrogate markers of visceral fat and response to anti-depressive treatment in patients with major depressive disorder: a prospective exploratory analysis.
Tønning M; Petersen D; Steglich-Petersen M; Csillag C
Nord J Psychiatry; 2017 Feb; 71(2):110-114. PubMed ID: 27701935
[TBL] [Abstract][Full Text] [Related]
14. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
[TBL] [Abstract][Full Text] [Related]
15. History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.
Oriolo G; Huet L; Dexpert S; Beau C; Forestier D; Ledaguenel P; Magne E; Martin-Santos R; Capuron L
Brain Behav Immun; 2019 Feb; 76():215-222. PubMed ID: 30476563
[TBL] [Abstract][Full Text] [Related]
16. Obesity among outpatients with major depressive disorder.
Papakostas GI; Petersen T; Iosifescu DV; Burns AM; Nierenberg AA; Alpert JE; Rosenbaum JF; Fava M
Int J Neuropsychopharmacol; 2005 Mar; 8(1):59-63. PubMed ID: 15361263
[TBL] [Abstract][Full Text] [Related]
17. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
18. Is Obesity A Determinant Of Success With Pharmacological Treatment For Depression? A Systematic Review, Meta-Analysis And Meta-Regression.
Grigolon RB; Trevizol AP; Gerchman F; Bambokian AD; Magee T; McIntyre RS; Gomes FA; Brietzke E; Mansur RB
J Affect Disord; 2021 May; 287():54-68. PubMed ID: 33773359
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
[TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
